Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE ...

Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that insights from the LifeVest® wearable cardioverter defibrillator (WCD) helped physicians ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new analyses from the HELIOS-B Phase 3 study of vutrisiran in patients with the cardiomyopathy of ...

An estimated 60 million scripts are dispensed for this type of beta blocker every year—but more than 17,000 bottles are now ...

A new review in Current Cardiology Reviews maps how heart failure management is shifting toward precision medicine—pairing proven therapies (notably SGLT2 inhibitors across the ejection fraction ...

Subgroup analyses suggest an individualized approach may be helpful, but the findings are not definitive, one expert says.

A new ICMR-funded study involving NIMS reveals that rising heart failure treatment costs are pushing many Hyderabad families ...

Olive had been taken to the funeral directors’, I started to notice my heart beating irregularly; and it really scared me.

Exercise can strengthen the heart when done safely but heart patients should choose moderate activities, avoid overexertion ...

Why it matters: Heart failure patients often leave hospitals without optimal drug regimens, despite strong evidence that guideline-directed therapy extends life. What’s new: The ASSIST-HF AI system ...